Patents Represented by Attorney Robert S. Honr
  • Patent number: 4956381
    Abstract: .alpha.-[10-oxy-4H-benzo[4,5]cycloheptal[1,2-b]thiophen-4-ylidene]-carboxyl ic acids, or physiologically-hydrolysable and -acceptable esters or pharmaceutically acceptable salts thereof are useful for effecting monokine inhibition, in particular interleukin-1 release or secretion inhibition, as a therapeutic means other than anti-inflammatory or anti-pyretic means.
    Type: Grant
    Filed: October 25, 1988
    Date of Patent: September 11, 1990
    Assignee: Sandoz Ltd.
    Inventors: Pietro Bollinger, Hans U. Gubler, Jorg Schnyder